Robert F. Kennedy Jr. announced that the U.S. Food and Drug Administration (FDA) is removing warnings on estrogen-based hormone replacement therapy products for women. This decision marks a significant change in the regulatory stance on these therapies.
The announcement was made on November 10, 2025. The FDA"s action is expected to impact the availability and perception of hormone replacement therapies, which are commonly used to manage symptoms associated with menopause.
For more information on related coverage, refer to recent developments in politics.
Image for RFK Jr. announces FDA is removing warnings on estrogen-based hormone therapy
![[Video] Zuckerberg and wife expand Biohub initiative with AI for disease prevention](/_next/image?url=%2Fapi%2Fimage%2Fthumbnails%2Fthumbnail-1762628451897-ipdm5q-thumbnail.jpg&w=3840&q=75)
![[Video] Trump urges to lower tariffs on India after halt in Russian oil purchases](/_next/image?url=%2Fapi%2Fimage%2Fthumbnails%2Fthumbnail-1762809049942-prba8q-thumbnail.jpg&w=3840&q=75)
